Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet-fed rabbits.
atherosclerosis
coronary artery
nitric oxide
redox state
soluble guanylate cyclase
Journal
Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
02
04
2021
accepted:
29
06
2021
entrez:
21
7
2021
pubmed:
22
7
2021
medline:
12
2
2022
Statut:
ppublish
Résumé
This study aimed to investigate how atherosclerosis affects the soluble guanylate cyclase (sGC) system in coronary arteries. Rabbits were fed a normal diet for 12 weeks (N group) or a diet containing high cholesterol (1%) for 4 weeks (S-HC group) and 12 weeks (L-HC group). Cholesterol deposition in the intima of coronary arteries was observed in the S-HC group, but the formation of an atherosclerotic plaque was not observed. In contrast, a major plaque developed in the L-HC group. The relaxant response of isolated coronary arteries to sodium nitroprusside (SNP, nitric oxide donor) was not different between the N and S-HC groups, whereas the response in the L-HC group was markedly attenuated. The relaxation induced by BAY 60-2770 (sGC activator) tended to be augmented in the S-HC group, but it was significantly impaired in the L-HC group compared to that in the N group. sGC β1 immunostaining was equally detected in the medial layer of the arteries among the N, S-HC, and L-HC groups. In addition, a strong staining was observed in the plaque region of the L-HC group. cGMP levels in the arteries stimulated with SNP were identical in the N and S-HC groups and slightly lower in the L-HC group than the other groups. BAY 60-2770-stimulated cGMP formation tended to be increased in the S-HC and L-HC groups. These findings suggest that the sGC system was not normal in atherosclerotic coronary arteries. The redox state of sGC and the distribution pattern are likely to change with the progression of atherosclerosis.
Identifiants
pubmed: 34289251
doi: 10.1002/prp2.838
pmc: PMC8294056
doi:
Substances chimiques
Cholesterol, Dietary
0
Soluble Guanylyl Cyclase
EC 4.6.1.2
Cyclic GMP
H2D2X058MU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e00838Informations de copyright
© 2021 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.
Références
Pharmacol Rev. 2000 Sep;52(3):375-414
pubmed: 10977868
J Pharmacol Sci. 2014;125(2):169-75
pubmed: 24859780
Redox Biol. 2017 Aug;12:70-81
pubmed: 28214453
Circ J. 2009 Apr;73(4):595-601
pubmed: 19225203
Pharmacol Res Perspect. 2016 Sep 16;4(5):e00261
pubmed: 27713826
Arterioscler Thromb. 1993 Jun;13(6):771-6
pubmed: 7684605
N Engl J Med. 2013 May 23;368(21):2004-13
pubmed: 23697515
J Cardiovasc Pharmacol. 2020 May;75(5):475-482
pubmed: 32141988
Arterioscler Thromb. 1994 Jun;14(6):931-7
pubmed: 8199184
PLoS One. 2016 Jan 04;11(1):e0146212
pubmed: 26727368
Mol Cell Biochem. 2005 Jan;269(1-2):1-11
pubmed: 15786711
J Am Coll Cardiol. 1994 Feb;23(2):452-8
pubmed: 8294700
Am J Physiol Heart Circ Physiol. 2016 Jun 1;310(11):H1439-47
pubmed: 27037373
Annu Rev Biochem. 2012;81:533-59
pubmed: 22404633
Exp Anim. 1999 Jan;48(1):1-7
pubmed: 10067199
Am J Pathol. 2003 Oct;163(4):1567-77
pubmed: 14507663
Atherosclerosis. 2012 Aug;223(2):365-71
pubmed: 22721702
Peptides. 1993 Mar-Apr;14(2):359-64
pubmed: 8483814
Am J Physiol Heart Circ Physiol. 2014 Dec 1;307(11):H1565-75
pubmed: 25239802
Molecules. 2013 Oct 10;18(10):12548-60
pubmed: 24152674
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1578-86
pubmed: 19592462
J Cardiovasc Pharmacol. 1989;14 Suppl 11:S35-9
pubmed: 2484697
Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16671-6
pubmed: 15546990
PLoS One. 2018 Jul 9;13(7):e0200307
pubmed: 29985945
Circ Res. 1988 Feb;62(2):185-90
pubmed: 2448055
Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2192-7
pubmed: 11031203
Acta Physiol (Oxf). 2014 Apr;210(4):799-810
pubmed: 24299003
Int J Exp Pathol. 2005 Oct;86(5):335-45
pubmed: 16191105
Stroke. 2007 Oct;38(10):2698-705
pubmed: 17761918
J Vasc Res. 2019;56(3):109-116
pubmed: 31085923
Handb Exp Pharmacol. 2017;238:169-205
pubmed: 28204955
Atherosclerosis. 2011 Oct;218(2):431-4
pubmed: 21794866
J Clin Invest. 2006 Sep;116(9):2552-61
pubmed: 16955146
Circ Res. 2015 Mar 27;116(7):1120-32
pubmed: 25608528
Handb Exp Pharmacol. 2021;264:355-394
pubmed: 30689085
IUBMB Life. 1999 Oct;48(4):413-7
pubmed: 10632571
Arzneimittelforschung. 2008;58(2):71-80
pubmed: 18412020
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1448-1457
pubmed: 31043077
Am J Cardiol. 1989 Sep 1;64(8):433-9
pubmed: 2773786
Circulation. 2002 Feb 19;105(7):855-60
pubmed: 11854127